Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT (PAP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02081092 |
Recruitment Status :
Completed
First Posted : March 7, 2014
Last Update Posted : November 1, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Pulmonary Alveolar Proteinosis |
Study Type : | Observational |
Actual Enrollment : | 9 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT |
Study Start Date : | December 2013 |
Actual Primary Completion Date : | October 29, 2018 |
Actual Study Completion Date : | October 29, 2018 |
Group/Cohort |
---|
Pulmonary Alveolar Proteinosis (PAP)
Patients diagnosis with Pulmonary Alveolar Proteinosis.
|
- Comparing MRI's images pre and post whole lung lavage [ Time Frame: 24 hours before lung lavage and 24-48 hours after lung lavage ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 8 Years to 75 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Clinically diagnosed PAP scheduled for lung lavage with double lumen endoscopy.
- Children patients ≥ 8 years of age
- Adult patients ≤ 75 years of age
- Medically stable as per the opinion of Bruce Trapnell, MD or Robert Wood, MD
- Patient and or parent consent obtained
Exclusion Criteria:
- Standard MRI exclusion criteria as set forth by the CCHMC Division of Radiology
- Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02081092
United States, Ohio | |
Cincinnati Children's Hospital Medical Center | |
Cincinnati, Ohio, United States, 45229 |
Principal Investigator: | Jason Woods, MD | Children's Hospital Medical Center, Cincinnati |
Responsible Party: | Children's Hospital Medical Center, Cincinnati |
ClinicalTrials.gov Identifier: | NCT02081092 |
Other Study ID Numbers: |
2013-7051 |
First Posted: | March 7, 2014 Key Record Dates |
Last Update Posted: | November 1, 2018 |
Last Verified: | October 2018 |
PAP Pulmonary Alveolar Proteinosis Pulmonary Patients |
Pulmonary Alveolar Proteinosis Lung Diseases Respiratory Tract Diseases |